STOCKHOLM & WASHINGTON--(BUSINESS WIRE)--Tobii Technology, the global leader in eye tracking and gaze interaction, has selected a behavioral research team that used eye-tracking technology to enhance the understanding and diagnosis of supranuclear palsy as the winners of the annual Tobii EyeTrackAwards. The Award recognizes cutting-edge research projects that uncover new insights made possible through the application of eye-tracking technology and analysis. This prestigious global award will be presented to the winning researchers at the annual EyeTrackBehavior Conference in Leuven, Belgium, Oct. 9-10.
“We are extremely honored to recognize these individuals, as they have added significant knowledge to the application of eye tracking in diagnostics, developed new insights and contributed to the greater knowledge base within the clinical research community,” said Tom Englund, president of analysis solutions at Tobii. “The EyeTrackAwards allow Tobii to elevate forward-thinking researchers and showcase the various ways eye-tracking analysis can contribute to a greater understanding of behavioral and psychological research challenges.”
Every year, as the leading global provider of scientific research eye tracking products, Tobii solicits the submission of eye-tracking-enabled research studies to be considered for recognition through the Tobii EyeTrackAwards, as the company seeks to expand the recognition and application of eye-tracking analysis across all areas of research.
Members of this year’s award-winning team include Susana Martinez-Conde, Jorge Otero-Millan, Alessandro Serra, R. John Leigh, Xoana G. Troncoso and Stephen L. Macknik. The group’s study, titled “Distinctive Features of Saccadic Intrusions and Microsaccades in Progressive Supranuclear Palsy,” used eye tracking to study eye movement abnormalities in the disease, which is often misdiagnosed as Parkinson’s disease. The team was selected for the Tobii award on the basis of the incredible potential impact these research findings may have on the cognitive, behavioral and medical communities as well as its application of groundbreaking research methods and detailed analysis of eye-tracking data collected for the study.
"We hope that our study’s results will enhance early diagnosis of PSP, lead to accessible approaches by which eye movements can be used to evaluate treatments, and provide insights into the pathogenesis of this devastating disorder,” said Susana Martinez-Conde, the study’s leading researcher and the keynote speaker at the EyeTrackBehavior Conference.
Tobii will showcase the winners of the 2012 EyeTrackAwards at the EyeTrackBehavior Conference, a two-day annual conference hosted by Tobii giving academic researchers the opportunity to exchange theories and methodologies about eye-tracking technology and applications.
Register for the EyeTrackBehavior conference 2012 here through Sept. 30. Speaker and other presentation opportunities are still open.
Nominations for the 2012 EyeTrackAwards can be submitted at www.eyetrackawards.com.
About Tobii Technology
Tobii Technology is the global market leader in eye tracking and eye control. The company’s products are widely used within the scientific community and in commercial market research and usability studies, as well as by people with disabilities as a means to communicate. Tobii also drives innovation of eye-tracking technology in many other areas, offering OEM components for integration into various industry applications, such as for use in hospitals, engineering, sports and entertainment. Founded in 2001, the company has received numerous awards for its technology innovations and its rapid financial growth. Tobii is based in Stockholm, Sweden, and has offices in the U.S., Germany, Norway, Japan and China. More information: www.tobii.com.